Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORASURE TECHNOLOGIES INC Director's Dealing 2017

Feb 16, 2017

33573_dirs_2017-02-16_e53e4886-e2e7-40e9-97ce-ee4e02241239.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORASURE TECHNOLOGIES INC (OSUR)
CIK: 0001116463
Period of Report: 2017-02-15

Reporting Person: JERRETT JACK E (SVP & General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-15 Common stock M 25000 $6.625 Acquired 80842 Direct
2017-02-15 Common stock M 43850 $7.045 Acquired 124692 Direct
2017-02-15 Common stock M 38438 $5.7149 Acquired 163130 Direct
2017-02-15 Common stock S 107288 $11.0588 Disposed 58842 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-15 Nonqualified stock option $6.625 M 25000 Disposed 2021-02-01 Common stock (25000) Direct
2017-02-15 Nonqualified stock option $7.045 M 43850 Disposed 2023-02-01 Common stock (43850) Direct
2017-02-15 Nonqualified stock option $5.7149 M 38438 Disposed 2024-02-03 Common stock (38438) Direct

Footnotes

F1: Nonqualified stock options granted on February 1, 2011 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.

F2: Nonqualified stock options granted on February 1, 2013 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.

F3: Nonqualified stock options granted on February 3, 2014 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.